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Abstract
Involvement of viruses in human neurodegenerative diseases and the underlying pathologic mechanisms remain generally unclear.
Human respiratory coronaviruses (HCoV) can infect neural cells, persist in human brain, and activate myelin-reactive T cells. As a means
of understanding the human infection, we characterized in vivo the neurotropic and neuroinvasive properties of HCoV-OC43 through the
development of an experimental animal model. Virus inoculation of 21-day postnatal C57BL/6 and BALB/c mice led to a generalized
infection of the whole CNS, demonstrating HCoV-OC43 neuroinvasiveness and neurovirulence. This acute infection targeted neurons,
which underwent vacuolation and degeneration while infected regions presented strong microglial reactivity and inflammatory reactions.
Damage to the CNS was not immunologically mediated and microglial reactivity was instead a consequence of direct virus-mediated
neuronal injury. Although this acute encephalitis appears generally similar to that induced by murine coronaviruses, an important difference
rests in the prominent spongiform-like degeneration that could trigger neuropathology in surviving animals.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Although the etiology of most neuroautoimmune, neu-
roinflammatory, and/or neurodegenerative diseases remains
unclear, virus infections could directly trigger neurodegen-
eration or initiate a CNS-directed inflammatory process
leading to central nervous system (CNS) damage, or a
combination of both. Indeed, Parkinson’s disease, Alzhei-
mer’s disease, amyotrophic lateral sclerosis (ALS), and
multiple sclerosis (MS) could actually represent infectious
diseases (Calne et al., 1986; Kristensson, 1992; Kirk and
Zhou, 1996; Allen et al., 1996; Hayase and Tobita, 1997;
Klein et al., 1999; Boucher et al., 2001; Jubelt and Berger,
2001; Giraud et al., 2001; Sola et al., 2002). Moreover,
psychiatric disorders were also investigated as a possible
consequence of viral infections (Waltrip et al., 1995; Lewis,
2001). The vertebrate CNS was long thought to be inacces-
sible to cells of the immune system or to viruses. However,
the presence of virus in the CNS is more frequent than
expected and viral detection in the cerebrospinal fluid of
patients suggests the ability of viruses to cross the blood-
brain barrier (Koskiniemi and Vaheri, 1989; Georgsson,
1994). In fact, neuroinvasive viruses can damage the CNS
and produce neurological disease in sensitive hosts, due to
the misdirected immune response of the host (virus-induced
immunopathology) and/or viral replication in cells of the
brain (virus-induced cytopathology). Nevertheless, primary
infections of the brain are not common and viruses are the
leading cause of encephalitis, which results from either
direct infection (acute encephalitis) or the immune response
to an infection (postinfectious encephalitis or acute demy-
elinating encephalomyelitis). In acute encephalitis, viral
replication occurs in the brain tissue itself, causing destruc-
tive lesions of the gray matter: this was reported after herpes
simplex, rabies, or some arbovirus infections (Rupprecht et
al., 2002; Shoji et al., 2002). Therefore, the knowledge of
infectious agents involved in neurological diseases and
mechanisms underlying the induction of neuropathology by
these pathogens will be invaluable for preventing and de-
veloping novel clinical interventions.
Coronaviruses are enveloped positive-stranded RNA vi-
ruses that infect multiple species of mammals, including
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man, causing diseases that range from encephalitis to en-
teritis. Human coronaviruses (HCoV) are recognized respi-
ratory pathogens responsible for up to 35% of common
colds (McIntosh, 1996; Myint, 1994) and also involved in
nocosomial infections (Sizun et al., 2000). They have oc-
casionally been associated with other pathologies, such as
pneumonia, meningitis, and enteritis (Riski and Hovi, 1980;
Resta et al., 1985). Moreover, HCoV have the ability to
replicate and persist in human neural cells (Bonavia et al.,
1997; Arbour et al., 1999a,b) and to have neuroinvasive
properties (Burks et al., 1980; Murray et al., 1992; Stewart
et al., 1992; Arbour et al., 2000). This has stimulated re-
search on their possible involvement in neurological disor-
ders. Of the two known HCoV serotypes, designated OC43
and 229E, HCoV-OC43 is antigenically related to murine
coronaviruses (MHV). Given that, under certain conditions,
MHV causes experimental CNS inflammatory demyelina-
tion that pathologically resembles MS (Bailey et al., 1949;
Lampert et al., 1973; Weiner, 1973; Wang et al., 1990), the
related human coronavirus represents a logical target for
investigation.
In the present study, we report the development of a
mouse model to characterize in vivo HCoV-OC43-mediated
neuropathogenesis. We describe the acute disease induced
by HCoV-OC43 infection, which resulted from neuronal
infection and loss. This animal model constitutes a tool to
study neuroinvasive and neurovirulence properties of a
common cold virus and the mechanisms underlying the
development of a diffuse vacuolating meningoencephalitis,
an emerging medical problem (Shoji et al., 2002; Whitley
and Gnann, 2002).
Results
Inoculation routes and virus doses
BALB/c and C57BL/6 mice were selected in view of
their relative susceptibility to both respiratory and enteric
strains of MHV (Barthold and Smith, 1987). We tried dif-
ferent inoculation routes to establish the neurotropic and
neuroinvasive properties of HCoV-OC43 in mice. An intra-
peritoneal inoculation with a virus dose of 105 TCID50
revealed that HCoV-OC43 virus infection could be lethal
until 8 days postnatal (DPN) and the same doses were
nonlethal at 21 DPN. With an intraoral inoculation of 104–
105 TCID50 of virus, we were unable to reveal the presence
of virus or virus gene products in any tissue tested (brain,
spinal cord, heart, lung, liver, and spleen), even by RT-PCR.
Mice were susceptible to intranasal (IN) inhalation of the
HCoV-OC43 solution at 104–105 TCID50. This infection
was lethal in 1-week-old C57BL/6 mice. However, 21 DPN
mice infected this way did not show clinical signs of pa-
thology, but 4 of the 8 animals were found positive for viral
RNA by RT- PCR analyses. Viral RNA was mainly found
in the CNS but some mice also showed virus RNA in the
spleen (data not shown). Therefore, virus could spread from
the periphery to the CNS after IN inhalation.
Having shown HCoV-OC43 neuroinvasive properties,
we chose for the remaining experimentation to use intrace-
rebral inoculation (IC) so as to favor a CNS infection. The
IC route results in a more reproducible infection, a better
control of viral doses introduced into the brain. The corre-
lation between viral infectious dose and 100% mortality in
the two strains of mice after inoculation is shown in Table
1. Mice became less susceptible with age and were resistant
at 35 DPN for C57BL/6 and at 28 DPN for BALB/c mice.
We then determined the optimal experimental conditions to
obtain a sublethal dose that still allowed virus replication
and virus-induced CNS pathology in 21-day-old mice. Viral
dose was administered under deep anesthesia and was de-
termined to be 10 l of a virus solution containing 10
TCID50 for C57BL/6 and 105 TCID50 for BALB/c mice
aged 21 DPN. Under these conditions, inoculated mice
developed signs of acute disease characterized by loss of
weight, apathy, ruffled fur, humped posture, and wasting
(Figs. 1A and B). Animals showed atrophy of skeletal
muscles and occasionally exhibited paralysis of their fore-
limbs. During the second week postinfection, some of the
animals recovered and clinical signs totally disappeared.
For others, pathological signs increased and led to death.
The infected animals became anorexic, inactive, and dehy-
drated, increasing percentages of mortality. We established
survival curves for each mouse strain (Fig. 1C). Eighty
percent of the C57BL/6 mice died within the first 15 days
postinfection and only 20% of BALB/c mice died during
this period, even after receiving a higher viral dose. More-
over, mice inoculated with supernatants from cell cultures
infected with brain tissue from affected mice developed the
same disease, demonstrating that the virus was responsible
for pathology.
Viral RNA and infectious virus
Viral RNA could be detected in the brain as early as 24 h
postinfection, and after 2 to 3 days in the spinal cord. All
C57BL/6 mice were positive for HCoV-OC43 RNA during
the first 11 days postinfection and during the first 9 days for
BALB/c mice (Figs. 2A and B). A screening of viral rep-
Table 1
Determination of infectious viral lethal dose for killing 100% of the
infected animals, using two strains of mice, after IC inoculation.
DPN C57BL/6 mice BALB/c mice
8 1–10 1–10
15 5–50 100–1000
21 50–100 100,000
28 100–1000 Nonlethal
35 Nonlethal Nonlethal
Note. This dose (expressed in TCID50) is in function of mouse age (days
postnatal; DPN) at the time of inoculation.
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lication was performed by RT-PCR in a variety of tissues
and results obtained indicated that infection was restricted
to the CNS during the first 9 days postinfection. After that,
in the most affected mice, viral RNA was also found in
heart, spleen, and lungs, and at lower levels in liver and
muscles between the 11th and 13th days postinfection in
C57BL/6, suggesting a viremic spread or transneuronal
transmission (Fig. 3B). The presence of HCoV-OC43 RNA
was detectable in the brain until 11 days postinfection for
40% of BALB/c mice and until 15 days postinfection for
25% of C57BL/6 mice. No viral RNA could be found from
tissues harvested after these times postinfection. It was also
confirmed that the RT-PCR assay designed to specifically
detect HCoV-OC43 was indeed specific and could not have
detected an enzootic MHV strain (Fig. 3C).
Infectious virus appeared around 3 days postinfection
and could be isolated from the CNS of C57BL/6 mice
during the first 2 weeks postinfection (Fig. 2A). The highest
levels of infectious virions were found between 5 and 9 days
postinfection (Fig. 2C). In BALB/c mice, virus was detect-
able at 1 day postinfection and reached the highest titer
around 3 days postinfection (Figs. 2B and C). The highest
infectious titers observed were 108 TCID50/g for brain and
106 TCID50/g for spinal cord extracts. No infectivity could
be detected at and after 13 days postinfection for C57BL/6
and 9 days postinfection for BALB/c mice.
Viral proteins were found in the brain and spinal cord of
C57BL/6 mice between 5 and 11 days postinfection (Fig.
3A) and were undetectable after 10 days postinfection. We
detected two forms of the N protein, as already noted in 8
DPN HCoV-OC43-inoculated mice (Jacomy and Talbot,
2001) or after MHV-4 infection (Talbot et al., 1984).
Blood collected at different time points after infection
revealed that serum contained antibodies specific for
HCoV-OC43. Humoral immunity started to appear at 1
week postinfection and increased during the first month
postinfection, and antiviral antibodies were still present at 4
months postinfection, as shown by indirect immunofluores-
cence on infected HRT-18 cells (data not shown). No im-
munofluorescent cells were seen with serum obtain from
control mice.
Histology
Histochemical labeling of viral distribution at different
times after infection revealed that virus infection initiated
by ic inoculation was quickly disseminated throughout the
CNS. Cells positive for viral antigens were first observed at
Fig. 1. Characterization of HCoV-OC43 infection. (A) Typical posture of an infected mouse at an advanced stage of disease when the animal presented highly
pronounced humped back with restrained mobility (9 DPN). (B) C57BL/6 mice were weighed every 2 days after infection to estimate weight variations.
HCoV-OC43-infected mice gained weight normally during the first 5 days after infection, after which they all lost weight during the acute phase of the
disease. The more affected mice lost more weight more rapidly than less affected mice and died during this period. After 9 days postinfection, mice which
survived gained weight to reach the weight of control animals around 21 days postinfection. (C) Survival curves of mice after HCoV-OC43 infection. BALB/c
mice received a higher dose than the C57BL/6 mice, 10,000 TCID50 versus 10 TCID50. However, C57BL/6 were less resistant, with 80 versus 20% of death
after infection.
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3 days postinfection in the gray matter of the brains of
C57BL/6 mice. At this time, microglial activation was still
undetectable as assessed by Mac-2 immunostaining. At 1
week postinfection, HCoV-OC43 had spread to all CNS
regions, predominantly in the entire cerebral cortex, the
striatum, the hippocampus, the hypothalamus areas, the
colliculus superior, and the brain stem, including the spinal
cord (Figs. 4 and 5). The cerebellum was frequently spared,
but Purkinje cells were found positive for virus in some
animals. Astrogliosis revealed by GFAP staining increased
and activated microglial cells started to appear along the
ventricles (Figs. 4F, G, and H). Activated microglial cells
were not observed in the CNS of noninfected control mice
at any time during investigation, as monitored by the ab-
sence of staining for Mac-2, a marker not expressed in
nonreactive microglia (Walther et al., 2000). In the spinal
cord at 7 days postinfection, an HCoV-OC43-specific MAb
labeled sensory and motor neurons, and microgliosis and
astrogliosis were also detected in infected regions (Fig. 5).
The progression of the infection was accompanied by
identical neuropathologic features in the two strains of
mice: neurons exhibited severe signs of pathology, most of
them showing necrosis and vacuolation. This started by the
development of small and round empty vacuoles in the
cytoplasm, which increased in size (Figs. 4C, D, and E).
These spongiform-like lesions were seen primarily within
the neuronal cell bodies, the neuropil being generally unaf-
fected (Fig. 6C). This feature was never observed in non-
infected brain (Fig. 6A). Ultrastructurally, numerous cells
presented cytoplasm disorganization without lysis of the
cellular membranes. Degenerative changes included cyto-
plasm rarefaction, dilatation of the rough endoplasmic re-
ticulum (RER), and disaggregation of polyribosomes lead-
ing to the appearance of free ribosomes. Hematoxylin-eosin
staining also revealed the presence of degenerated neurons
with picknotic or small densely stained nuclei and eosino-
philic cytoplasm (Figs. 6C, E, H, and I). At an advanced
stage of disease, loss of neurons was pronounced and was
particularly evident in CA1 and CA3 hippocampal layers
(Fig. 6D–I).
Histological examination of the brain or spinal cord
revealed scattered infiltration of inflammatory cells, starting
by mononuclear cell infiltrations (Fig. 6B) and perivascular
cuffing. Some macrophage-mediated elimination (neu-
Fig. 2. HCoV-OC43 infectious virus and RNA in the CNS of 21 DPN mice. (A) 100% of brains from C57BL/6 mice inoculated ic with 10 TCID50 of HCoV-
OC43 were positive for viral RNA between 3 and 11 days postinfection. Only 25% of the surviving mice were found positive after 15 days postinfection
and RNA was not found thereafter. Infectious virus appeared later and disappeared before elimination of viral RNA. Between 5 and 11 days postinfection,
100% of brains contained infectious virus. (B) Detection of HCoV-OC43 RNA in the brain of BALB/c mice inoculated ic with 105 TCID50 of HCoV-OC43
revealed that 100% of these mice were positive until 9 days postinfection. Infectious virus was detectable in all mice only during the first 3 days postinfection
and gradually fewer mice were found positive. (C) Histogram representing the amount of infectious virus detected in five brains from the two strains of mice
at different intervals postinfection. The limit of the detection assay was 100.5 TCID50.
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ronophagia) was also encountered. In the spinal cord, viral
particles observed 7 days postinfection at the electron mi-
croscopic level were mostly localized in the cell cytoplasm,
closely associated with the Golgi apparatus or in extracel-
lular spaces (Fig. 7). Viral replication and transneuronal
passage occurred in a stepwise fashion that utilized existing
cellular processes. When HCoV-OC43 replication and
spread reached maximal levels, around 9 days postinfection,
astrogliosis and microgliosis progressively increased in all
infected regions of the CNS until the death of the animal
(Figs. 4G and H). Therefore, a correlation between patho-
logical signs of disease observed in mice and morphological
injury of the brain was apparent.
Immunosuppression by CsA in C57BL/6
Clearance of MHV from the CNS appears to involve T
cells (Sussman et al., 1989) and age- acquired resistance to
virus could be abolished in immunosuppressed animals
(Zimmer and Dales, 1989). Therefore, we examined the
effect of immunosuppression on HCoV-OC43- mediated
neuropathogenesis. The immunosuppressive effects of cy-
closporin A (CsA) are clearly established (Borel et al.,
1976). As CsA causes a specific reversible inhibition of
immunocompetent lymphocytes (preferentially T cells) and
inhibits gene transcription for certain cytokines, in particu-
lar IL-2 (Kupiec-Weglinski et al., 1984; Elliott et al., 1984;
Shevach, 1985), we investigated whether CsA could modify
the course of the acute HCoV-OC43 infection on the devel-
opment of CNS lesions or on viral replication.
It is known that CsA injected into mice at 50 mg/kg/day
induces neurotoxicity (hypocellular and disorganized or-
gans), whereas CsA at 12.5 mg/kg/day induces no abnor-
malities and spread to all organs (Boland et al., 1984).
Therefore, CsA doses were selected to avoid cytotoxic ef-
fects and mortality in mice and were in accordance with
immunosuppression- inducing doses described in the liter-
ature (Bolton et al., 1982; Pasick et al., 1992). Control mice
treated with CsA at a daily dose of 20 mg/kg did not show
any apparent adverse effects: they gained weight normally
and did not present ruffled fur or lethargy. For CsA-treated
and untreated mice, the kinetics of weight loss was similar
after HCoV-OC43 infection. Nevertheless, immunosuppres-
sion by CsA slightly precipitated the disease but increased
mortality (Fig. 8). This was more pronounced in mice
treated with CsA at 20 mg/kg/day where 100% of mice died,
whereas only 80% of oil-treated mice succumbed to HCoV-
OC43 infection.
Discussion
Infection of mice by HCoV-OC43 was dependent on a
number of variables, including dose, route of inoculation,
age of the host, and its genetic background. Indeed, our
results show striking susceptibility differences between two
strains of mice: BALB/c mice were more resistant than
C57BL/6. Moreover, resistance increased with age in the
two strains of mice. This suggests that susceptibility to
human coronavirus neuropathogenesis may be linked to
genetic factors. Our study also confirms that human coro-
naviruses have neuroinvasive properties in mice, which was
first shown in newborn mice (Barthold et al., 1990), and that
such neuroinvasion is possible even after maturation of the
immune system (King et al., 1992), which is consistent with
their detection in human brain (Burks et al., 1980; Murray et
al., 1992; Stewart et al., 1992; Arbour et al., 2000). Even
though our study does not confirm a specific route of entry
into the CNS, a transneuronal route already demonstrated
for MHV (Lavi et al., 1988; Barthold et al., 1990; Perlman
et al., 1990a) constitutes a likely possibility.
Twenty-one days postnatal mice infected by ic inocula-
tion of HCoV-OC43 developed signs of acute disease char-
acterized by apathy, hunched posture, ruffled fur, and trem-
ors, comparable to pathological signs described after MHV
infection (Kristensson et al., 1986). Following IC inocula-
Fig. 3. Detection of proteins and RNA in brains of C57BL/6 mice inocu-
lated ic with HCoV-OC43 at 21 DPN. (A) Western blot analysis at 5 and
9 days postinfection, revealing the presence of the HCoV-OC43 N proteins
in inoculated mice (I1, I2, I3, and I4 mice) and its absence in control mice
(C1, C2, C3, and C4). (B) RT-PCR analysis revealed at 13 days postin-
fection that virus had spread from the CNS (B: brain; SC: spinal cord) to
other peripheric organs, such as heart (H), lungs (Lg), spleen (S), and to a
lesser extent, the liver (L) and muscles (M). HCoV-OC43 virus was never
found in kidneys (Ki) nor in intestine (I). The quality of RNA extraction
was estimated using GAPDH RNA detection. (C) RT-PCR analysis dem-
onstrating that HCoV-OC43 and not an enzootic MHV strain was detected.
HCoV-OC43 primers recognized HCoV-OC43 mRNA in B, SC, or S
tissues of an infected mouse as well as in control RNA (O: HCoV-OC43-
infected cells) but not MHV-A59 mRNA (A: MHV-infected cells). On the
other hand, on the same sample, MHV primers recognized only MHV-A59
mRNA but not HCoV-OC43 mRNA.
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tion, some mice developed disseminated infection, and mor-
tality seemed to be related to the amount of infectious virus
in the CNS. Mice inoculated IN with HCoV-OC43 did not
show pathological signs, despite evidence of a disseminated
infection. This was also previously observed after IN inoc-
ulation with MHV-A59, which caused only very mild
Fig. 4. Immunocytochemical staining of infected (21 DPN) C57BL/6 mice brains. HCoV-OC43-infected neurons stained in black in the cerebral cortex (A)
and in the CA1 layer of the hippocampus (B), 1 week after virus inoculation. In C, D, and E, HCoV-OC43-positive neurons exhibited empty vacuoles
(arrowheads) in the cytoplasm at 7 days postinfection, which increased at 9 and 11 days postinfection. Panels F, G, and H show reactive microgliosis in the
brain. At 7 days postinfection (F), Mac-2-stained cells started to appear along the lateral ventricle (LV) and became more numerous at 9 days postinfection
(G). H shows a magnification of microglial cells observed in G (CC: corpus callosus). A, B, H: original magnification: 200; F,G: magnification: 40; C,
D, E: 400.
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pathologic symptoms and mortality even with very high
viral doses (Lavi et al., 1986). The clinical signs of pathol-
ogy after HCoV-OC43 IC inoculation coincided with the
peak in virus yields observed at approximately 5 to 9 days
postinfection for C57BL/6 mice. This indicates that virus
replication in the CNS apparently played a major role in the
establishment of the pathology.
Infected mice showed extensive inflammatory responses
characterized by mononuclear perivascular cuffing, neu-
ronophagia, and a great number of reactive glial cells in the
Fig. 5. Immunocytochemical staining of the spinal cord of a C57BL/6 mouse (21 DPN) 1 week after HCoV-OC43 infection. (A, B, and C) Evidence of
inflammatory reaction on three consecutive sections of the cervical dorsal horn. (A): Antiviral MAb. (B) Mac-2 microglia/macrophages cell marker. (C):
GFAP astrocytic cell marker. (D): spongiosis aspect of gray matter revealed by toluidine blue staining. (E): Infection of motor neurons by HCoV-OC43 in
the ventral horn of the lumbar spinal cord. Magnification: 100 before enlargement.
26 H. Jacomy, P.J. Talbot / Virology 315 (2003) 20–33
Fig. 6. Cytotoxic effect of HCoV-OC43 infection in the CNS of C57BL/6 mice (21 DPN) at 11 days postinfection (hematoxylin and eosin staining) (A, B,
and C) Overview of the thalamus (original magnification: 200). (A) Control mice showing no degenerative changes. B (less affected animal) and C (more
affected animal) illustrate infiltrating cells and spongiform-like lesions (characterized by vacuolation in neuronal cell bodies) and degenerative neurons with
small densely stained nuclei or eosinophilic cytoplasm. (D) Normal hippocampus from control mice, with magnification of CA1 (F) and CA3 (G)
hippocampus layers. (E) After infection, degenerative changes appeared mostly in CA1 (H) and CA3 (I) hippocampal layers; degenerated neurons exhibited
picnotic nuclei and vacuolated cells were present in CA3 hippocampal layers (DG: Dentate Gyrus). (D and E) Magnification: 40; F, G, H, and I: original
magnification: 200.
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infected regions. To investigate whether infiltration of in-
flammatory cells contributed to neurodegeneration or if in-
fectious virus was directly responsible for vacuolating le-
sions and neuronal death, we evaluated the effect of treating
animals with cyclosporin A, a powerful immunosuppressant
drug. With the dose used (10 or 20 mg/kg/day), CsA is
known to be distributed extensively throughout the body
and not to cause neurotoxicity in mice (Boland et al., 1984).
Immunosuppression precipitated human coronavirus-in-
duced disease and increased the percentage of acute death
(80 vs 100%). Under CsA treatment, neurons also presented
vacuolation and degeneration. Therefore, the pathology ob-
served following HCoV- OC43 infection was likely not
immunologically mediated, unlike that induced by MHV-
A59 and MHV-JHM (Sussman et al., 1989; Wang et al.,
1990), although experiments with immunodeficient mice of
the same genetic background will be needed to definitely
address this question with HCoV-OC43. Moreover, macro-
phage/microglial reactivity was delayed when related to
infection and appeared only when the virus was present in
most parts of the brain. The inflammatory response and
macrophage/microglial cell recruitment seem to be strongly
correlated with virus clearance, as was also demonstrated
after MHV infection (Sussman et al., 1989). Some strains of
MHV, including A59 and JHM, are neuroinvasive in ro-
dents, eliciting either an acute encephalitis or a chronic
paralytic disease (for review, see Perlman, 1998). Unlike the
slow neurodegenerative disease caused by MHV (Bailey et
al., 1949; Lampert et al., 1973; Weiner, 1973; Lavi et al.,
1984; Wang et al., 1990), HCoV-OC43 resulted in a pro-
ductive and cytotoxic infection of neuronal cells in the CNS,
which led to neurodegeneration.
Fig. 7. Detection of HCoV-OC43 infection at the electron microscopic level, in the spinal cord of C57BL/6 mice infected 7 days previously. (A) Numerous
viral particles (arrows) were seen between the axons (A) and the dendrites (D). (B) Virus particles found in the endoplasmic reticulum of the cytoplasm
(original magnification: 20,000). (C) Magnification of B to show virions. Viral spikes around virions are typical of coronaviruses. No retroviral particles
were observed (original magnification: 40,000).
Fig. 8. Survival curves of infected mice treated with cyclosporin A (CsA).
Group of 10 C57BL/6 mice treated with cyclosporin A at 20 mg/kg/day
(OC43/20 mgCsA) and at 10 mg/kg/day (OC43/10 mgCsA) became more
susceptible to HCoV-OC43 infection, with 100 and 90% of death after
infection versus 80% in non-CsA-treated animal. Infected C57BL/6 mice
treated with oil alone (OC43/oil) presented similar survival curves as
previously reported, with 80% of death after infection. Noninfected HCoV-
OC43 mice treated with CsA at 20 mg/kg/day (Control/20 mgCsA) illus-
trated that CsA was not toxic under these conditions.
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Having previously demonstrated a persistent infection of
HCoV-OC43 in primary murine CNS cell cultures and in
the CNS of mice inoculated at 8DPN (Jacomy and Talbot,
2001), and given the observations that MHV antigens or
RNA were still detectable in the spinal cord several weeks
after infection (Woyciechowska et al., 1984; Perlman et al.,
1990b), we expected to detect a persistent infection in the
CNS of infected 21 DPN mice. However, RT- PCR analysis
revealed that viral RNA could not be detected after the
second week postinfection, suggesting a nonpersistent in-
fection of HCoV-OC43 virus in 21 DPN mice.
Histological analysis of infected 21 DPN mice showed
virus spread throughout the brain and spinal cord, as we had
previously described for 8 DPN mice (Jacomy and Talbot,
2001). Neurons remained the major cellular targets for vi-
rus, which was probably disseminated from neurons to
neurons by a cell-to-cell transport, as was described after
MHV infection (Lavi et al., 1988; Sun and Perlman, 1995).
Nevertheless, even though neurons were susceptible to
MHV infection, oligodendrocytes and astrocytes repre-
sented the major infected cell types (Perlman and Ries,
1987; Sun and Perlman, 1995; Sun et al., 1995). This may
explain why the pathology observed in mice was different
after infection with these two antigenically related corona-
viruses: MHV can cause demyelination (Bailey et al., 1949;
Lampert et al., 1973; Weiner, 1973; Wang et al., 1990) with
a spongy state observed in the white matter (Lavi et al.,
1984), whereas HCoV-OC43 encephalitis is accompanied
by vacuolating degeneration of the gray matter. The latter
lesions were not detected in a previous study (Pearson and
Mims, 1983; Barthold et al., 1990), probably because mice
were younger and died within 3 to 7 days postinfection.
Spongiform cellular changes were occasionally reported
after MHV infection. For example, vacuolation was ob-
served in the subthalamic- nigral region after ic inoculation
of MHV-A59 (Fishman et al., 1985), and foci of vacuolation
were observed in the hypothalamus, cerebellar peduncles,
and pons regions after IN inoculation of MHV-S (Barthold
and Smith, 1983). Nevertheless, these degenerative changes
were not commonly observed after MHV infection and were
restricted to small cell populations, even after infection with
300- to 600-fold higher virus doses into C57BL/6 mice.
Interestingly, the appearance of clear round vacuoles and
neuronal death represents a hallmark of CNS degeneration
observed in prion diseases (Prusiner, 1998). Nevertheless,
mitochondrial disease (McKelvie et al., 1991), Leigh’s dis-
ease (Kimura et al., 1991; Agapitos et al., 1997), Pick’s
disease (Deruaz et al., 1993), or Alzheimer’s disease (Duffy
et al., 1988; Budka et al., 1995) also display spongiform
CNS lesions, which are independent of the prion protein.
Pathways and causal start points of transmissible spongi-
form encephalopathies or acute encephalitis remain un-
known. Occasionally, viral infections of the CNS were
described to induce spreading spongiosis, such as in human
T cell leukemia virus associated myelopathy (HTLV-1) or
in HIV encephalitis (Rhodes, 1987; Goldwater and Paton,
1989). In rodents, mutants of VSV virus (Rabinowitz et al.,
1976) and Moloney murine leukemia virus (Mo-MuLV)
(Gardner et al., 1973; Czub et al., 1994) were shown to
experimentally induce spongiosis. Histologically, vacuolar
degeneration induced by HCoV-OC43 was mainly re-
stricted to the neuronal cell bodies, whereas that caused by
prion or retrovirus first affected the neuropil. Moreover, the
inflammatory response was very limited in prion encepha-
lopathy, whereas HCoV-OC43 induced extensive brain in-
flammation. These indicate different mechanisms underly-
ing vacuolation and neuronal death.
Interestingly, noninflammatory neuropathologies have
been considered evidence against a viral etiology. Infections
by opportunistic pathogens such as respiratory or enteric
virus in immuosuppressed patients (HIV, transplantation,
and cancer chemotherapy) may also cause CNS pathology.
It has been reported that immunocompromised patients have
increased incidences of malignancies induced by viral in-
fection (Penn, 1987). Therefore, severe cases of encephalitis
have devastating effects on the brain and spinal cord func-
tions. Given our previous observations of HCoV-OC43 per-
sistence in human brain (Stewart et al., 1992; Arbour et al.,
2000), we propose that respiratory pathogens with a neuro-
tropic and neuroinvasive potential could be associated with
neurodegenerative disease in susceptible individuals. This
animal model of human coronavirus neuropathogenesis may
prove helpful in the characterization of coronavirus-induced
neurodegeneration in surviving infected animals and of
transneuronal virus spread to the CNS. Moreover, suscep-
tibilities of endothelial cells and leukocytes to viral infec-
tion need to be investigated as a possible alternate route of
virus entry into the CNS. Finally, possible explanations for
our observations of striking differences in susceptibility to
HCoV-OC43 infection of two strains of mice remain to be
investigated.
Even though mice are not the natural host for HCoV-
OC43 infections, they may provide data that, together with
studies using human neural cell cultures and post-mortem
brain tissue, may contribute to our understanding of the
underlying mechanisms and neuropathological conse-
quences of coronavirus infections in humans.
Materials and methods
Virus, mice, and inoculations
The OC43 strain of HCoV was originally obtained from
the American Type Culture Collection (ATCC, Rockville,
MD), plaque-purified, and grown on the human rectal car-
cinoma cell line HRT-18 as previously described (Mounir
and Talbot, 1992). HCoV- OC43 virus stocks (106 TCID50/
ml) were kept at 80°C.
To determine the susceptibility of mice to HCoV-OC43
infection, two different strains of MHV-seronegative female
mice (BALB/c and C57BL/6, from Jackson Laboratories,
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Bar Harbor, ME, U.S.A.) were inoculated. Inoculations
were performed on mice at various days postnatal (1, 8, 15,
21, 28, 35 DPN) using 10 l of various dilutions of the
initial virus stock and using different inoculation routes:
intraperitoneal, intraoral, intranasal, and intracerebral, to
investigate HCoV-OC43 infection parameters, in particular
its neuroinvasive property. The viral dose was administrated
IC under deep anesthesia of ketamine-xylamine (ketamine
at 200 mg/kg and xylamine at 10 mg/kg). In the present
study, we chose to infect 21 DPN mice with an IC inocu-
lation of 10 l containing 10 TCID50 of HCoV-OC43 for
C57BL/6 and 10,000 TCID50 for BALB/c mice. Twenty
mice of each strain were used to establish survival curves.
Every 2 days postinfection, five animals from two groups of
infected mice of each strain were sacrificed and processed
for detection of viral RNA, viral proteins, and infectious
virus. Moreover, two infected mice of each strain were
perfused every 2 days for histological analysis during the
first month postinfection. For each experiment, age-matched
control animals, which had received a virus-free solution
containing culture medium from the HRT-18 cell line, were
used.
To confirm that HCoV-OC43 was responsible for the
observed pathology, we infected HRT-18 cell cultures with
brain homogenates, prepared as described below, from in-
fected mice. Cell-free supernatants harvested 4 days later
were confirmed to contain infectious virus and 10 l was
reinoculated IC into other animals.
Immunosuppression by cyclosporin A
Cyclosporin A (Sigma Chemical Co., St. Louis, MO)
was rehydrated in pure ethanol as specified by the manu-
facturer. It was then dissolved before use in olive oil to
favor free diffusion of hydrophobic cyclosporin molecules
through the plasma membrane into the cytoplasm (Hands-
chumacher et al., 1984), and heated for 2 h at 60°C. Mice
received a subcutaneous injection of 10 or 20 mg/kg/day.
This drug was administered 1 day prior to virus inoculation
and daily thereafter for 10 days. Three groups of 10 female
C57BL/6 mice were infected with 10 TCID50 of HCoV-
OC43 and 8 control females were inoculated with HRT-18
medium. Two groups of HCoV-OC43-infected mice re-
ceived a single daily injection of CsA, either 10 or 20
mg/kg/day. Four control mice and the third group of HCoV-
OC43- infected mice received injection of olive oil alone.
The four remaining control mice were treated with CsA at
20 mg/kg/day, to verify the absence of CsA toxicity.
Infectious virus assays
Brain and spinal cords were dissected, homogenized in
10% (w/v) sterile PBS, centrifuged at 4°C, 20 min at 1000
g; then supernatants were immediately frozen at80°C and
stored until assayed. The extracts were processed for the
presence and quantification of infectious virus by an indirect
immunohistochemistry assay, as previously described
(Bonavia et al., 1997). HCoV-OC43-susceptible HRT-18
cells were inoculated with serial logarithmic dilutions of
each tissue sample in a 96-well Linbro plate (ICN Biomed-
ical Canada Ltd., Costa Mesa, CA). After 4 days of incu-
bation at 33°C in 5% (v/v) CO2, cells were washed in PBS
and fixed with 0.3% (v/v) hydrogen peroxide (H2O2) in
methanol for 30 min. After washing with PBS, they were
incubated for 2 h at 37°C in 1/1000 dilution of an ascites
fluid from mouse MAb 1–10C.3, directed against the nu-
cleocapsid protein of HCoV-OC43 (Arbour et al., 1999b).
Afterwards, cells were washed in PBS and HRP goat anti-
mouse immunoglobulins (DAKO, Diagnostics Canada Inc.,
Mississauga, ON) were added and incubated for 2 h at 37°C.
Antibody complexes were detected by incubation in 3.3-
diaminobenzidine tetrahydrochloride solution (DAB,
Sigma), with 0.01% (v/v) H2O2.
Immunohistochemistry
Mice were perfused by intraventricular injection of 4%
(v/v) paraformaldehyde, under deep ketamine-xylazine an-
esthesia. Brains and spinal cords were removed and tissue
blocks were left in the fixative for 24 h. Coronal sections
from brain and segments from cervical and lumbar spinal
cord were sectioned at a thickness of 40 m with a Lancer
vibratome. Serial sections were collected in 0.05 M Tris-
buffered saline (TBS) and were then incubated overnight
with primary antibodies, as previously described (Jacomy
and Bosler, 1996). For viral antigens, we used 1/1000 dilu-
tions of ascites fluids of the 4-E11.3 hybridoma that secretes
monoclonal antibodies specific for the nucleocapsid protein
of the serologically related hemagglutinating encephalomy-
elitis virus of pigs (Bonavia et al., 1997). Astrocytes were
identified with a rabbit anti glial fibrillary acidic protein
antibody (GFAP, DAKO) diluted 1/500, microglia/macro-
phages by an ascites fluid of the rat Mac-2 antibody (ATCC)
diluted 1/1000. Then, sections were rinsed and processed
with Vectastain ABC Kit (Vector Laboratories, Burlingame,
CA). Labeling was revealed with 0.03% (w/v) DAB solu-
tion (Sigma) and 0.01% (v/v) H2O2, which yielded a dark
brown product. Some sections were counterstained with the
classical Cresyl violet stain. To further investigate histolog-
ical changes occurring in mouse brains, half hemispheres
from control and infected animals were paraffin-embedded
and 10-m sections were stained with hematoxylin-eosin.
This was performed by the Pathology Department, Animal
Resources Centre, McGill University (Montre´al, Que´bec,
Canada).
Samples for electron microscopy were postfixed for 2 h
with 2% (v/v) osmium tetraoxide in 0.1 M phosphate buffer
at pH 7.5, dehydrated in graded ethanol series, and Epon-
embedded as previously described (Jacomy and Bosler,
1996). One-micron sections were stained with toluidine
blue and examined by light microscopy. Subsequent ultra-
thin sections were collected on collodion-coated single-slot
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grids, stained with lead citrate, and examined with trans-
mission electron microscope.
Detection of antiviral antibodies
Blood from infected or control mice were collected at 1,
2, 3, or 4 weeks and at 2, 3, and 4 months postinfection. Sera
were collected and kept at 20°C until use for the detection
of antibodies against HCoV-OC43 by indirect immunoflu-
orescent labeling of infected HRT-18 cells. Briefly, HRT-18
cells cultured on 12-well slides were infected by HCoV-
OC43 and fixed 4 days later in cold methanol and then kept
at 20°C until needed. At the time of the assays, slides
were incubated 1 h at room temperature with serum from
control and infected mice, diluted 1/100, 1/500, and 1/1000.
After several washes in PBS, slides were incubated 1 h at
37°C with Alexa Fluor 488 F(ab)2 fragments of goat anti-
mouse IgG (HL), at a dilution of 1/15,000 (Molecular
Probes, Inc., Eugene, OR) and observed under a fluores-
cence microscope.
Western blot analyses
Tissues were homogenized in SUB buffer, containing 8
M urea, 0.5% (w/v) SDS, and 2% (v/v) -mercaptoethanol
and then centrifuged for 15 min at 4°C, in a microfuge at
13,000 g and supernatants were collected, as previously
described (Jacomy et al., 1999). Samples (5 g total pro-
tein) were fractionated on a 7.5% polyacrylamide gel (SDS–
PAGE) and either visualized by Coomassic blue staining or
transferred to nitrocellulose for Western blot analysis. Ni-
trocellulose membranes were preincubated in 5% (w/v)
skimmed milk powder in TS buffer (0.05 M Tris, pH 7.4,
0.15 M NaCl) and then incubated overnight at 4°C with
4E11.3 antiviral MAB. After several washes with TS buffer
containing 0.05% (v/v) Tween 20, membranes were incu-
bated 1 h with peroxidase-conjugated anti-mouse IgG di-
luted 1/1000 (DAKO). Bands were visualized using a West-
ern blot chemoluminescent kit (Super Signal, Pierce,
Rockford, MD).
Preparation of RNA and RT-PCR
Tissues were dissected every 2 days postinfection. Total
RNA was extracted by homogenization in Trizol (Gibco-
BRL, Burlington, CA). For RT-PCR, one pair of HCoV-
OC43 primers was designed to amplify a region containing
305 nucleotides (primers O1 and O3) of the gene coding for
the N protein (Arbour et al., 1999b). The target sequences
were specific to HCoV-OC43 and did not amplify MHV.
The suitability of RNA for RT-PCR amplification was verified
by an RT-PCR specific for a housekeeping gene encoding
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) using a
pair of GAPDH primers amplifying a region containing 833
nucleotides (Arbour et al., 1999b). One pair of MHV primers
was also designed to amplify a conserved region of the MHV
N protein gene. Primers were 5-CCTCTACTGTAAAACCT-
GATATGG-3 and 5-CTAATTTAGATCCAAAGAAGA-
AGC-3, corresponding to nucleotides 677–700 and 868–991,
respectively. Approximately 5 g of RNA was reverse tran-
scribed with Expand Moloney murine leukemia virus reverse
transcriptase (Gibco-BRL) and the cDNA products were incu-
bated in 20 pmol of each sense and antisense primers, 2.5 mM
MgCl2, 1 PCR buffer (10 mM Tris–HCl, pH 8.3; 50 mM
KCl), and 0.4 mM of each deoxynucleotide triphosphate,
heated at 94°C for 5 min and 60°C (HCoV-OC43) or 50°C
(GAPDH and MHV) for 5 min. After the addition of Expand
high-fidelity PCR system DNA polymerase (rTaq, 5000 U/l;
Amersham Pharmacia Biotech Inc., Baie d’Urfe´, QC), 30 am-
plification cycles of 2 min at 72°C, 1 min at 95°C, and 2 min
at 60°C (HCoV-OC43) or 50°C (GAPDH and MHV) were
performed. Ten microliters of this reaction mix was loaded
onto a 1.2% (w/v) agarose gel containing 5 l ethidium bro-
mide.
Acknowledgments
We thank Annie Boucher, INRS-Institut Armand-Frap-
pier, for the critical review of the manuscript and Francine
Lambert for excellent technical assistance. We also thank
Dr. Serge Dea (who tragically passed away on January 3,
2003), INRS-Institut Armand-Frappier, for the generous gift
of the 4-E11.3 antibody, and Dr. Yves Robitaille, McGill
University, for constructive comments on neuropathology.
We also thank the McGill University Animal Resources
Centre for their help with some histology. This work was
supported by Grant MT-9203 from the Canadian Institutes
of Health Research (Institute of Infection and Immunity).
References
Agapitos, E., Pavlopoulos, P.M., Patsouris, E., Davaris, P., 1997. Subacute
necrotizing encephalopathy (Leigh’s disease): a clinicopathologic
study of ten cases. Gen. Diag. Pathol. 142, 355–341.
Allen, I.V., McQuaid, S., McMahon, J., Kirk, J., McConnell, R., 1996. The
significance of measles virus antigen and genome distribution in the
CNS in SSPE for mechanisms of viral spread and demyelination.
J. Neuropathol. Exp. Neurol. 55, 471–480.
Arbour, N., Coˆte´, G., Lachance, C., Tardieu, M., Cashman, N.R., Talbot,
P.J., 1999b. Acute and persistent infection of human neural cell lines by
human coronavirus OC43. J. Virol. 73, 3338–3350.
Arbour, N., Day, R., Newcombe, J., Talbot, P.J., 2000. Neuroinvasion by
human respiratory coronaviruses and association with multiple sclero-
sis. J. Virol. 74, 8913–8921.
Arbour, N., Ekande´, S., Coˆte´, G., Lachance, C., Chagnon, F., Tardieu, M.,
Cashman, N.R., Talbot, P.J., 1999a. Persistent infection of human
oligodendrocytic and neuroglial cell lines by human coronavirus 229E.
J. Virol. 73, 3326–3337.
Bailey, O.T., Pappenheimer, A.M., Cheever, F.S., Daniels, J., 1949. A
murine virus (JHM) causing disseminated encephalomyelitis with ex-
tensive destruction of myelin. II. Pathology. J. Exp. Med. 90, 195–212.
Barthold, S.W., Smith, A.L., 1983. Mouse hepatitis virus S in weanling
Swiss mice following intranasal inoculation. Lab. Anim. Sci. 33, 355–
360.
31H. Jacomy, P.J. Talbot / Virology 315 (2003) 20–33
Barthold, S.W., Smith, A.L., 1987. Response of genetically susceptible and
resistance mice to intranasal inoculation with mouse hepatitis virus
JHM. Virus Res. 7, 225–239.
Barthold, S.W., de Souza, M.S., Smith, A.L., 1990. Susceptibility of
laboratory mice to intranasal and contact infection with coronaviruses
of other species. Lab. Anim. Sci. 40, 481–485.
Boland, J., Atkinson, K., Britton, K., Darveniza, P., Johnson, S., Biggs, J.,
1984. Tissue distribution and toxicity of cyclosporin A in the mouse.
Pathology 16, 117–123.
Bolton, C., Allsopp, G., Cuzner, M.L., 1982. The effect of cyclosporin A
on the adoptive transfer of experimental allergic encephalomyelitis in
the Lewis rat. Clin. Exp. Immunol. 47, 127–132.
Bonavia, A., Arbour, N., Wee Yong, V., Talbot, P.J., 1997. Infection of
primary cultures of human neural cells by human coronavirus 229E and
OC43. J. Virol. 71, 800–806.
Borel, J.F., Feurer, C., Gubler, H.U., Stahelin, H., 1976. Biological effects
of Cyclosporin A: a new antilymphocytic agent. Agents Actions 6,
468–475.
Boucher, A., Denis, F., Duquette, P., Talbot, P.J., 2001. Generation from
multiple sclerosis patients of long-term T-cell clones that are activated
by both human coronavirus and myelin antigens. Adv. Exp. Med. Biol.
494, 355–362.
Budka, H., Aguzzi, A., Brown, P., Brucher, J.M., Bugiani, O., Gullotta, F.,
Haltia, M., Hauw, J.J., Ironside, J.W., Jellinger, K., et al., 1995. Neu-
ropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD)
and other human spongiform encephalopathies (prion diseases). Brain
Pathol. 5, 459–466.
Burks, J.S., DeVald, B.L., Jankovsky, L.D., Gerdes, J.C., 1980. Two
coronaviruses isolated from central nervous system tissue of multiple
sclerosis patients. Science 209, 933–934.
Calne, D.B., Eisen, A., McGeer, E., Spencer, P., 1986. Alzheimer’s dis-
ease, Parkinson’s disease, and motoneuron disease: abiotrophic inter-
action between ageing and environment. Lancet 8, 1067–1070.
Czub, S., Lynch, W.P., Czub, M., Portis, J.L., 1994. Kinetic analysis of
spongiform neurodegenerative disease induced by a highly virulent
murine retrovirus. Lab. Invest. 70, 711–723.
Deruaz, J.P., Assal, G., Peter-Favre, C., 1993. A clinicopathological case of
progressive aphasia. Rev. Neurol. (Paris) 149, 186–191.
Duffy, P., Mayeux, R., Kupsky, W., 1988. Familial Alzheimer’s disease
with myoclonus and “spongy change.” Arch. Neurol. 45, 1097–1100.
Elliott, J.F., Lin, Y., Mizel, S.B., Bleackley, R.C., Harnish, D.G., Paetkau,
V., 1984. Induction of interleukin 2 messenger RNA inhibited by
cyclosporin A. Science 226, 1439–1441.
Fishman, P.S., Gass, J.S., Swoveland, P.T., Lavi, E., Highkin, M.K.,
Weiss, S.R., 1985. Infection of the basal ganglia by a murine corona-
virus. Science 30, 877–879.
Gardner, M.B., Henderson, B.E., Officer, J.E., Rongey, R.W., Parker, J.C.,
Oliver, C., Estes, J.D., Huebner, R.J., 1973. A spontaneous lower motor
neuron disease apparently caused by endogenous type-C RNA virus in
wild mice. J. Natl. Cancer Int. 51, 1243–1254.
Georgsson, G., 1994. Neuropathologic aspects of lentiviral infections. Ann.
NY Acad. Sci. 6, 50–67.
Giraud, P., Beaulieux, F., Ono, S., Shimizu, N., Chazot, G., Lina, B., 2001.
Detection of enteroviral sequences from frozen spinal cord samples of
Japanese ALS patients. Neurology 26, 1777–1778.
Goldwater, P.N., Paton, J.C., 1989. Apparent non-involvement of prions in
the pathogenesis of spongiform change in HIV-infected brain. J. Neu-
ropathol. Exp. Neurol. 48, 184–186.
Handschumacher, R.E., Harding, M.W., Rice, J., Drugge, R.J., Speicher,
D.W., 1984. Cyclophilin: a specific cytosolic binding protein for cy-
closporin A. Science 226, 544–547.
Hayase, Y., Tobita, K., 1997. Influenza virus and neurological diseases.
Psychiatry Clin. Neurosci. 51, 181–184.
Jacomy, H., Bosler, O., 1996. Intrinsic organization and monoaminergic
innervation of the suprachiasmatic nucleus transplanted to adult rats. A
light- and electronic- microscopic study. J. Neurocytol. 25, 659–673.
Jacomy, H., Talbot, P.J., 2001. Susceptibility of murine CNS to OC43
infection. Adv. Exp. Med. Biol. 494, 101–107.
Jacomy, H., Zhu, Q., Couillard-Despres, S., Beaulieu, J.M., Julien, J.P.,
1999. Disruption of type IV intermediate filament network in mice
lacking the neurofilament medium and heavy subunits. J. Neurochem.
73, 972–984.
Jubelt, B., Berger, J.R., 2001. Does viral disease underlie ALS? Lessons
from the AIDS pandemic. Neurology 57, 945–946.
Kimura, S., Kobayashi, T., Amemiya, F., 1991. Myelin splitting in the
spongy lesion in Leigh encephalopathy. Pediatr. Neurol. 7, 56–58.
King, L.E., Morford, L.A., Gibbons, J.P., Fraker, P.J., 1992. Flow cyto-
metric analysis of the expression of murine B and T surface markers
from the birth to adulthood. Immunol. Lett. 31, 73–78.
Kirk, J., Zhou, A.L., 1996. Viral infection at the blood-brain barrier in
multiple sclerosis: an ultrastructural study of tissues from a UK Re-
gional Brain Bank. Mult. Scler. 1, 242–252.
Klein, R., Mullges, W., Bendszus, M., Woydt, M., Kreipe, H., Roggendorf,
W., 1999. Primary intracerebral Hodgkin’s disease: report of a case
with Epstein–Barr virus association and review of the literature. Am. J.
Surg. Pathol. 23, 477–481.
Koskiniemi, M., Vaheri, A., 1989. Effect of measles, mumps, rubella
vaccination on pattern of encephalitis in children. Lancet 7, 31–34.
Kristensson, K., Holmes, K.V., Duchala, C.S., Zeller, N.K., Lazzarini,
R.A., Dubois-Dalcq, M., 1986. Increased levels of myelin basic protein
transcripts in virus-induced demyelination. Nature 322, 544–547.
Kristensson, K., 1992. Potential role of viruses in neurodegeneration. Mol.
Chem. Neuropathol. 16, 45–58.
Kupiec-Weglinski, J.W., Filho, M.A., Strom, T.B., Tilney, N.L., 1984.
Sparing of suppressor cells: a critical action of cyclosporine. Trans-
plantation 38, 97–101.
Lampert, P.W., Sims, J.K., Kniazeff, A.J., 1973. Mechanism of demyeli-
nation in JHM virus encephalomyelitis. Acta Neuropathol. 24, 76–85.
Lavi, E., Gilden, D.H., Wroblewska, Z., Rorke, L.B., Weiss, S.R., 1984.
Experimental demyelination produced by the A59 strain of mouse
hepatitis virus. Neurology 34, 597–603.
Lavi, E., Gilden, D.H., Highkin, M.K., Weiss, S.R., 1986. The organ
tropism of mouse hepatitis virus A59 in mice is dependent on dose and
route of inoculation. Lab. Anim. Sci. 36, 130–135.
Lavi, E., Fishman, P.S., Highkin, M.K., Weiss, S.R., 1988. Limbic en-
cephalitis after inhalation of a murine coronavirus. Lab. Invest. 58,
31–36.
Lewis, D.A., 2001. Retroviruses and pathogenesis of schizophrenia. Proc.
Natl. Acad. Sci. USA 98, 4293–4294.
McIntosh, K., 1996. in: Fields, B.N., Knipe, D.M., et al. (Eds.), Virology,
third ed. Raven Press, New York, pp. 1095–1103.
McKelvie, P.A., Morley, J.B., Byrne, E., Marzuki, S., 1991. Mitochondrial
encephalomyopathies: a correlation between neuropathological find-
ings and defects in mitochondrial DNA. J. Neurol. Sci. 102, 51–60.
Mounir, S., Talbot, P.J., 1992. Sequence analysis of the membrane protein
gene of human coronavirus OC43 and evidence for O-glycosylation.
J. Gen. Virol. 73, 2731–2736.
Murray, R.S., Brown, B., Brian, D., Cabirac, G.F., 1992. Detection of
coronavirus RNA and antigen in multiple sclerosis brain. Ann. Neurol.
31, 525–533.
Myint, S.H., 1994. Human coronavirus—a brief review. Rev. Med. Virol.
4, 35–46.
Pasick, J.M., Wilson, G.A., Morris, V.L., Dales, S., 1992. SJL/J resistance
to mouse hepatitis virus-JHM-induced neurologic disease can be par-
tially overcome by viral variants of S and host immunosuppression.
Microb. Pathog. 13, 1–15.
Pearson, J., Mims, C.A., 1983. Selective vulnerability of neural cells and
age-related susceptibility to OC43 virus in mice. Arch. Virol. 77,
109–118.
Penn, I., 1987. Cancers following cyclosporine therapy. Transplantation
43, 32–35.
32 H. Jacomy, P.J. Talbot / Virology 315 (2003) 20–33
Perlman, S., Ries, D., 1987. The astrocyte is a target cell in mice persis-
tently infected with mouse hepatitis virus, strain JHM. Microb. Pathog.
3, 309–1449.
Perlman, S., 1998. Pathogenesis of coronavirus-induced infections. Review
of pathological and immunological aspects. Adv. Exp. Med. Biol. 440,
503–513.
Perlman, S., Evans, G., Afifi, A., 1990a. Effect of olfactory bulb ablation
on spread of a neurotropic coronavirus into the mouse brain. J. Exp.
Med. 172, 1127–1132.
Perlman, S., Jacobsen, G., Olson, A.L., Afifi, A., 1990b. Identification of
the spinal cord as a major site of persistence during chronic infection
with a murine coronavirus. Virology 175, 418–426.
Prusiner, S.B., 1998. Prions. Proc. Natl. Acad. Sci. USA 95, 13363–13383.
Rabinowitz, S.G., Dal Canto, M.C., Johnson, T.C., 1976. Comparison of
central nervous system disease produced by wild-type and temperature-
sensitive mutants of vesicular stomatis virus. Infect. Immunol. 13,
1242–1249.
Resta, S., Luby, J.P., Rosenfeld, C.R., Siegel, J.D., 1985. Isolation and
propagation of a human enteric coronavirus. Science 229, 978–981.
Rhodes, R.H., 1987. Histopathology of the central nervous system in the
acquired immunodeficiency syndrome. Hum. Pathol. 18, 636–643.
Riski, N., Hovi, T., 1980. Coronavirus infections of man associated with
diseases other than the common cold. J. Med. Virol. 6, 259–265.
Rupprecht, C.E., Hanlon, C.A., Hemachudha, T., 2002. Rabies re-exam-
ined. Lancet Infect. Dis. 2, 327–343.
Shevach, E.M., 1985. The effects of cyclosporin A on the immune system.
Annu. Rev. Immunol. 3, 397–423.
Shoji, H., Azuma, K., Nishimura, Y., Fujimoto, H., Sugita, Y., Eizuru, Y.,
2002. Acute viral encephalitis: the recent progress. Intern. Med. 41,
420–428.
Sizun, J., Yu, M.W., Talbot, P.J., 2000. Survival of human coronaviruses
229E and OC43 in suspension and after drying on surfaces: a possible
source of hospital-acquired infections. J. Hosp. Infect. 46, 55–60.
Sola, P., Bedin, R., Casoni, F., Barrozzi, P., Mandrioli, J., Merelli, E.,
2002. New insights into the viral theory of amyotrophic lateral sclero-
sis: study on the possible role of Kaposi’s sarcoma-associated virus/
human herpesvirus 8. Eur. Neurol. 47, 108–112.
Stewart, J.N., Mounir, S., Talbot, P.J., 1992. Human coronavirus gene
expression in the brains of multiple sclerosis patients. Virology 191,
502–505.
Sun, N., Grzybicki, D.M., Castro, R.F., Murphy, S.P., Perlman, S., 1995.
Activation of astrocytes in the spinal cord of mice chronically infected
with a neurotropic coronavirus. Virology 213, 482–493.
Sun, N., Perlman, S., 1995. Spread of a neurotropic coronavirus to spinal
cord white matter via neurons and astrocytes. J. Virol. 69, 633–641.
Sussman, M.A., Shubin, R.A., Kyuwa, S., Stohlman, S.A., 1989. T-cell-
mediated clearance of mouse hepatitis virus strain JHM from the
central nervous system. J. Virol. 63, 3051–3056.
Talbot, P.J., Knobler, R.L., Buchmeier, M.J., 1984. Western and dot
immunoblotting analysis of viral antigens and antibodies: application to
murine hepatitis virus. J. Immunol. Methods 73, 177–188.
Walther, M., Kuklinski, S., Pesheva, P., Guntinas-Lichius, O., Angelov,
D.N., Neiss, W.F., Asou, H., Probstmeier, R., 2000. Galectin-3 is
upregulated in microglial cells in response to ischemic brain lesions,
but not to facial nerve axotomy. J. Neurosci. Res. 15, 430–435.
Waltrip 2nd., R.W., Buschanan, R.W., Summerfelt, A., Breier, A., Car-
penter, W.T., Bryant, N.L., Rubin, S.A., Carbone, K.M., 1995. Borna
disease virus and schizophrenia. Psychiatry Res. 56, 33–44.
Wang, F.I., Stohlman, S.A., Fleming, J.O., 1990. Demyelination induced
by murine hepatitis virus JHM strain (MHV-4) is immunologically
mediated. J. Neuroimmunol. 30, 31–34.
Weiner, L.P., 1973. Pathogenesis of demyelination induced by mouse
hepatitis virus. Arch. Neurol. 28, 298–303.
Whitley, R.J., Gnann, J.W., 2002. Viral encephalitis: familiar infections
and emerging pathogens. Lancet 359, 507–13.
Woyciechowska, J.L., Trapp, B.D., Patrick, D.H., Shekarchi, I.C., Leini-
kki, P.O., Sever, J.L., Holmes, K.V., 1984. Acute and subacute demy-
elination induced by mouse hepatitis virus strain A59 in C3H mice. J.
Exp. Pathol. 1, 295–306.
Zimmer, M.J., Dales, S., 1989. In vivo and in vitro models of demyelinat-
ing diseases XXIV. The infectious process in cyclosporin A treated
Winstar Lewis rats inoculated with JHM virus. Microbial Pathog. 6,
7–16.
33H. Jacomy, P.J. Talbot / Virology 315 (2003) 20–33
